Treatment Access Solution

A collaboration with Celgene Thailand

Pomalyst® (pomalidomide)

The Max Foundation partners with Celgene Thailand to increase access to Pomalyst® (pomalidomide) through the IMiDs Patient Assistance Program (I-PAP) for multiple myeloma patients in Thailand who meet the medical criteria and program guidelines.

Contact us for more information about how to access Pomalyst® for multiple myeloma patients in Thailand.

Return to Treatment Access Solutions